Human papillomaviruses (HPVs) are very important pathogens that can be classified as high-and low-risk types based on the lesions they cause. Mucosal high-risk HPV E6 can target and degrade the tumour suppressor p53, hence it is recognized as the major cause of cervical cancer, however, due to a lack of reliable anti-E6 antibodies, the distribution of high-risk HPV E6 protein remains elusive. The present study, therefore, used a mammalian green fluorescent protein (GFP) expression system to express GFP-18 E6 fusion proteins in wild-type p53 cells, SMMC-7721 and HCT116, in order to trace the location and expression of HPV E6 and p53 protein.
Introduction
Human papillomaviruses (HPVs) are small double-stranded DNA viruses with a genome of approximately 8 kb. The most prevalent high-risk types for inducing cervical cancer are HPV-18 and HPV-16. 1 The mechanisms underlying the cancer-causing actions of HPVs have been studied extensively, and it has been shown that E6 and E7 oncoproteins interact with the tumour suppressors p53 and pRB, respectively, leading to infected-cell transformation and dysregulated proliferation. 2, 3 Previous studies have also shown that the principal activity of E6 was to target and degrade p53, leading to p53 losing its growth regulatory functions. 4 The tumour suppressor protein p53 regulates cell cycle progression and cell survival in response to a wide range of cellular stresses, such as oncogenic activation, hypoxia, DNA damage or viral infection. Most of the functions of p53 seem to depend on its nuclear location by transactivating other genes and causing cell cycle arrest or apoptosis. 5, 6 Therefore, the subcellular distribution of p53 partly contributes to its function. Little is known about whether the overexpression of high-L Sun, G Zhang, Z Li et al. p53 and HPV-18 E6 protein in wild-type p53 cells and low-risk HPV E6 proteins alters the distribution of p53 protein.
The distribution HPV E6 protein has been controversial: high-risk HPV E6 was found to have nuclear, cytoplasmic, and both nuclear and cytoplasmic distributions. 7, 8 Due to the lack of reliable anti-E6 antibodies and the risk of introducing artifacts into the protein distribution from the fixation procedures, 9 we have made fusion proteins of E6 with green fluorescent protein (GFP) for use as a tool to trace the subcellular location of E6 protein. A mammalian GFP expression system was used to express full-length HPV-18 E6 protein in the p53 wild-type cell lines, SMMC-7721 and HCT116. Using fluorescence microscopy, we studied the location of E6 and p53 in transfected cells. The E6 fusion proteins may have a low or high expression level at different times, which may have an effect on the distribution of E6, therefore we dynamically observed the location and expression of proteins from 6 to 72 h post-transfection.
Materials and methods

PLASMID CONSTRUCTION
The mammalian expression vector, pEGFP-C1, was purchased from Clontech (Palo Alto, CA, USA). Full length HPV-18 E6 was amplified by polymerase chain reaction (PCR) from HPV type 18 complete genomes and then cloned in frame within the C terminus of the expression vector pEGFP-C1, producing plasmid pGFP-18 E6.
CELL CULTURE AND TRANSFECTION
Human hepatic cancer SMMC-7721 cells and colon carcinoma HCT116 cells were maintained in RPMI 1640 medium (Gibco ® Invitrogen™, Carlsbad, CA, USA) supplemented with 10% fetal bovine serum at 37°C in a humidified atmosphere of 5% CO 2 . The cells were seeded at approximately 30% confluency on glass coverslips in 12-well cell culture plates and transiently transfected overnight with plasmid pGFP-18 E6 and pGFP using Lipofectamine™ 2000 Transfection Reagent (Invitrogen™, Carlsbad, CA, USA) following the manufacturer's recommendations. The reagent-DNA ratio was 2:1.
CELL IMAGING BY FLUORESCENCE MICROSCOPY
The SMMC-7721 and HCT116 cells were grown on glass coverslips, transfected and at 6 -72 h post-transfection were fixed with 4% paraformaldehyde for 10 min at room temperature. They were then rehydrated three times with cold 10 mM phosphatebuffered saline (PBS) pH 7.4, stained with 4,6-diamidino-2-phenylindole (DAPI) at 37°C in the dark for 10 min, rinsed again with PBS and then mounted on slides. Images of cells were collected with a Nikon fluorescence microscope (Nikon, Tokyo, Japan) at ×400 magnification.
IMMUNOCYTOCHEMISTRY
The cells were seeded on glass coverslips at a density of 100 000 or 200 000 cells/well. Then, they were transfected overnight with plasmid pGFP-18 E6 and pGFP following standard procedures. After transfection, the cells were washed with PBS and fixed with 4% paraformaldehyde for 10 min at room temperature. They were then rehydrated three times with cold PBS, permeabilized with 1% Triton ® X-100 for 5 min on ice, then rinsed with PBS and blocked. The cells were incubated overnight with a primary antibody against p53 (Cell Signaling Technology, Danvers, MA, USA; dilution 1:500), at 4°C. Subsequently, signal detection was performed using Cy3-conjugated goat anti-rabbit immunoglobulin G (IgG) (Sigma, St Louis, MO, USA; dilution 1:200) in L Sun, G Zhang, Z Li et al. p53 and HPV-18 E6 protein in wild-type p53 cells blocking solution for 30 min at room temperature in the dark. Then the cells were washed three times with PBS and examined by fluorescence microscopy.
STATISTICAL ANALYSIS
All data are expressed as mean ± SD. Statistical evaluation of the data was carried out using the Statistical Package for Social Sciences (SPSS ® version 11.0; SPSS Inc., Chicago, IL, USA). Analysis of data was performed using one-way analysis of variance (ANOVA) for multiple comparisons. A P-value < 0.05 was considered to be statistically significant.
Results
SUBCELLULAR DISTRIBUTION AND EXPRESSION OF HPV-18 E6 PROTEIN
Using GFP fusion protein, the location and expression of GFP-18 E6 protein and GFP alone (control) were observed from 6 to 72 h post-transfection, reflecting the location and expression of HPV-E6 in SMMC-7721 and Fig. 1 .
The GFP-18 E6 protein was found to be expressed essentially in the nucleus from 6 h post-transfection and expression increased gradually, reaching a maximum at 21 h (P < 0.001), after which it then decreased gradually (Fig. 2 ).
CO-LOCALIZATION OF HIGH-RISK HPV-18 E6 AND ENDOGENOUS WILD-TYPE P53
Immunocytofluorescence staining indicated that wild-type p53 protein was mainly located in the nucleus of untreated and control pGFP-transfected cells. Importantly, GFP-18 E6 protein was clearly observed colocalized with p53 protein in the nucleus of both the SMMC-7721 and HCT116 cell lines (Fig. 3 ).
Discussion
The function of E6 protein is partly dependent on its location within the cell. 10 Previous studies on the localization of HPV-E6 protein have led to contradictory results, most probably due to the low level of endogenous E6 protein and the poor reactivity of the available anti-E6 antibodies. 9, 10 In the present study, viral E6 coding regions were inserted within the C terminus of the pEGFP-C1 vector, allowing E6 proteins to be expressed as GFP-E6 fusion proteins. These GFP fusion proteins were used to trace dynamically the subcellular GFP is a convenient, genetically encoded intrinsic fluorescent molecular label that has been widely and successfully used to study protein distribution in cells. 11 Our results suggest that HPV-18 E6 is mainly expressed in the nucleus. This is consistent with the study by Tao et al. 9 who showed that, in COS-1 cells, high-risk fulllength E6 protein was distributed predominantly in the nucleus. Thus, it seems likely that the localization of HPV-18 E6 in the nucleus is consistent with E6 having some transcription factors, 12 -14 including p300/CBP, interferon regulatory factor 3 (IRF-3) and c-Myc, or transcriptional coactivators, 15 as cellular binding partners and that this is why high-risk E6 proteins may cause more phenotypic changes within cells compared with their low-risk counterparts. About 50% of tumour cells contain mutated p53 but only wild-type p53 is detected in HPV sequence positive tumours. 16 We chose SMMC-7721 and HCT116 cells, because they are wild-type p53 cell lines and could partly stimulate HPV-infected cells. We observed E6 expression and distribution dynamically and obtained the same results for high-risk HPV-E6 location in both cells, as noted above.
The tumour suppressor, p53, causes cell cycle arrest or apoptosis in response to DNA damage and other forms of stress. 17 -19 The localization of p53 in the nucleus is essential for it to act as a transcription factor and modification of the subcellular distribution of p53 is an important regulatory mechanism. 20, 21 To determine whether the presence of E6 altered the subcellular localization of p53, we transfected cells with GFP-tagged HPV-18 E6 plasmids. Our results showed that the distribution of p53 protein did not change, and it was mainly located in the nucleus together with the expression of HPV-18 E6. These data were consistent with Liang et al. 8 who claimed that the presence of E6 did not alter the cellular localization of p53.
The present study demonstrated the colocalization of p53 and high-risk HPV-18 E6 in transfected cells. Using immunofluorescence techniques, we observed that p53 was located in the nucleus together with high-risk HPV-18 E6. This is supported by the fact that p53 has binding sites for high-risk HPV-E6 protein. 22 Since the interaction of p53 with HPV-E6 plays a very important role in carcinogenesis, 23 it is possible that the high-risk HPV-18 E6 located in nuclei might target and degrade p53. This may be one of the reasons that high-risk HPV is associated with cancer.
In conclusion, the present study indicated that high-risk HPV-18 E6 protein is predominantly located in the nucleus together with p53 in both SMMC-7721 and HCT116 cell lines. This study, therefore, provided a new insight into the pathogenesis of high-risk HPV-E6.
